Daniel J. Hughes
Floor 5, 1 Lambeth Palace Rd, London SE1 7EU
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Independent Testing of Published CT Models for PD-L1 Status in Non-Small Cell Lung Cancer.
Journal: Radiology
Published: March 31, 2026
Treatment and outcomes of immunotherapy related colitis and hepatitis- a multi-centre cohort study in the United Kingdom by the National Oncology Trainee Collaborative for Healthcare Research (NOTCH).
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: December 14, 2025
PD-L1 imaging with [99mTc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancer.
Journal: British journal of cancer
Published: August 08, 2024
Entrectinib-Induced Myocarditis and Acute Heart Failure Responding to Steroid Treatment: A Case Report.
Journal: JTO clinical and research reports
Published: July 26, 2024
The effects of anti-PD-1 therapy on programmed death-ligand 1 expression and glucose metabolism of normal organs in patients with advanced non-small cell lung cancer.
Journal: BJR open
Published: March 29, 2024
The use of self-expanding metallic stents in the management of benign colonic obstruction: a systematic review and meta-analysis.
Journal: Techniques in coloproctology
Published: February 06, 2024
Diagnostic and predictive ability of hyperbilirubinemia severity in cats: A multicenter retrospective study.
Journal: Journal of veterinary internal medicine
Published: October 24, 2023
Inter-rater and intra-rater agreement of [99mTc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer.
Journal: EJNMMI research
Published: March 01, 2023
Last Updated: 09/26/2026